Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 131

    1.

    Breast cancer prognosis by combinatorial analysis of gene expression data.

    Alexe G, Alexe S, Axelrod DE, Bonates TO, Lozina II, Reiss M, Hammer PL.

    Breast Cancer Res. 2006;8(4):R41.

    PMID:
    16859500
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Mixture classification model based on clinical markers for breast cancer prognosis.

    Zeng T, Liu J.

    Artif Intell Med. 2010 Feb-Mar;48(2-3):129-37. Epub 2009 Dec 14.

    PMID:
    20005686
    [PubMed - indexed for MEDLINE]
    3.

    Logical analysis of diffuse large B-cell lymphomas.

    Alexe G, Alexe S, Axelrod DE, Hammer PL, Weissmann D.

    Artif Intell Med. 2005 Jul;34(3):235-67.

    PMID:
    16023562
    [PubMed - indexed for MEDLINE]
    4.

    Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.

    Karlsson E, Delle U, Danielsson A, Olsson B, Abel F, Karlsson P, Helou K.

    BMC Cancer. 2008 Sep 8;8:254.

    PMID:
    18778486
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

    Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

    Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

    PMID:
    16959170
    [PubMed - indexed for MEDLINE]
    Free Article
    6.

    Meta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulation.

    Smith DD, Saetrom P, Snøve O Jr, Lundberg C, Rivas GE, Glackin C, Larson GP.

    BMC Bioinformatics. 2008 Jan 28;9:63.

    PMID:
    18226260
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    A clinical prognostic prediction of lymph node-negative breast cancer by gene expression profiles.

    Jiang D, Zhao N.

    J Cancer Res Clin Oncol. 2006 Sep;132(9):579-87. Epub 2006 Jun 8.

    PMID:
    16761122
    [PubMed - indexed for MEDLINE]
    8.

    TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer.

    Langerød A, Zhao H, Borgan Ø, Nesland JM, Bukholm IR, Ikdahl T, Kåresen R, Børresen-Dale AL, Jeffrey SS.

    Breast Cancer Res. 2007;9(3):R30.

    PMID:
    17504517
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    [Prognostic molecular classification of breast cancers based on gene expression profiling].

    Feng YM, Li XQ, Sun BC, Gao XC, Gu L, Niu Y, Hao XS.

    Zhonghua Zhong Liu Za Zhi. 2006 Dec;28(12):900-6. Chinese.

    PMID:
    17533740
    [PubMed - indexed for MEDLINE]
    10.

    Merging microarray data from separate breast cancer studies provides a robust prognostic test.

    Xu L, Tan AC, Winslow RL, Geman D.

    BMC Bioinformatics. 2008 Feb 27;9:125.

    PMID:
    18304324
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.

    Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, Desmedt C, Ignatiadis M, Sengstag T, Schütz F, Goldstein DR, Piccart M, Delorenzi M.

    Breast Cancer Res. 2008;10(4):R65. Epub 2008 Jul 28.

    PMID:
    18662380
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    12.

    Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets.

    Martin KJ, Patrick DR, Bissell MJ, Fournier MV.

    PLoS One. 2008 Aug 20;3(8):e2994.

    PMID:
    18714348
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.

    Yau C, Fedele V, Roydasgupta R, Fridlyand J, Hubbard A, Gray JW, Chew K, Dairkee SH, Moore DH, Schittulli F, Tommasi S, Paradiso A, Albertson DG, Benz CC.

    Breast Cancer Res. 2007;9(5):R59.

    PMID:
    17850661
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Using support vector regression to model the correlation between the clinical metastases time and gene expression profile for breast cancer.

    Chiu SH, Chen CC, Lin TH.

    Artif Intell Med. 2008 Nov;44(3):221-31. Epub 2008 Aug 3.

    PMID:
    18678474
    [PubMed - indexed for MEDLINE]
    15.

    Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data.

    Grigoriadis A, Mackay A, Reis-Filho JS, Steele D, Iseli C, Stevenson BJ, Jongeneel CV, Valgeirsson H, Fenwick K, Iravani M, Leao M, Simpson AJ, Strausberg RL, Jat PS, Ashworth A, Neville AM, O'Hare MJ.

    Breast Cancer Res. 2006;8(5):R56.

    PMID:
    17014703
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    Identification of new genes associated with breast cancer progression by gene expression analysis of predefined sets of neoplastic tissues.

    Cimino D, Fuso L, Sfiligoi C, Biglia N, Ponzone R, Maggiorotto F, Russo G, Cicatiello L, Weisz A, Taverna D, Sismondi P, De Bortoli M.

    Int J Cancer. 2008 Sep 15;123(6):1327-38.

    PMID:
    18561318
    [PubMed - indexed for MEDLINE]
    17.

    Identification of gene transcript signatures predictive for estrogen receptor and lymph node status using a stepwise forward selection artificial neural network modelling approach.

    Lancashire LJ, Rees RC, Ball GR.

    Artif Intell Med. 2008 Jun;43(2):99-111. Epub 2008 Apr 16.

    PMID:
    18420392
    [PubMed - indexed for MEDLINE]
    18.

    Improved breast cancer prognosis through the combination of clinical and genetic markers.

    Sun Y, Goodison S, Li J, Liu L, Farmerie W.

    Bioinformatics. 2007 Jan 1;23(1):30-7. Epub 2006 Nov 26.

    PMID:
    17130137
    [PubMed - indexed for MEDLINE]
    Free Article
    19.

    Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

    Bueno-de-Mesquita JM, van Harten WH, Retel VP, van't Veer LJ, van Dam FS, Karsenberg K, Douma KF, van Tinteren H, Peterse JL, Wesseling J, Wu TS, Atsma D, Rutgers EJ, Brink G, Floore AN, Glas AM, Roumen RM, Bellot FE, van Krimpen C, Rodenhuis S, van de Vijver MJ, Linn SC.

    Lancet Oncol. 2007 Dec;8(12):1079-87. Epub 2007 Nov 26. Erratum in: Lancet Oncol. 2008 Jan;9(1):10.

    PMID:
    18042430
    [PubMed - indexed for MEDLINE]
    20.

    Challenges in projecting clustering results across gene expression-profiling datasets.

    Lusa L, McShane LM, Reid JF, De Cecco L, Ambrogi F, Biganzoli E, Gariboldi M, Pierotti MA.

    J Natl Cancer Inst. 2007 Nov 21;99(22):1715-23. Epub 2007 Nov 13.

    PMID:
    18000217
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk